Nefrosol Fără Potasiu

Sodium hydrogen carbonate, magnesium chloride hexahydrate, sodium chloride, calcium chloride dihydrate, the active ingredient in Nefrosol Fără Potasiu, is an electrolyte solution presented as a solution for injection for intravenous use. It helps correct electrolyte and acid‑base imbalances in patients requiring fluid therapy.

GNH USA supplies Nefrosol Fără Potasiu as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Nefrosol Fără Potasiu is used as an intravenous electrolyte solution to address fluid and electrolyte disturbances. - Electrolyte replacement: restores sodium, chloride, magnesium and calcium levels in patients with deficits. - Metabolic acidosis correction: provides bicarbonate to buffer excess acidity. - Peri‑operative fluid management: maintains intravascular volume and electrolyte balance during surgery. - Trauma and shock resuscitation: supports circulatory volume and restores ion homeostasis.

Nefrosol Fără Potasiu may be associated with the following adverse reactions.

Common Side Effects: - Infusion site irritation: mild pain or redness at the injection site. - Mild hypernatremia: slight elevation of serum sodium levels. - Mild hypercalcemia: modest increase in calcium concentration. - Metabolic alkalosis: mild shift toward higher blood pH.

Serious or Rare Side Effects: - Severe hypernatremia: marked sodium excess causing neurological symptoms. - Severe hypercalcemia: dangerous calcium elevation leading to cardiac arrhythmia. - Anaphylactic reaction: rare severe allergic response requiring immediate treatment.

When using Nefrosol Fără Potasiu, consider the following precautions. - Renal impairment: monitor electrolyte levels closely. - Cardiac disease: avoid rapid infusion rates. - Pregnancy: use only if clearly needed. - Concurrent potassium supplements: may exacerbate hypokalemia. - Store at ambient temperature: keep in original container, protect from light and moisture.

Nefrosol Fără Potasiu can interact with other medicines.

Major Interactions (Avoid): - Concurrent hypertonic saline: risk of severe hypernatremia. - Calcium channel blockers: may potentiate calcium load. - Loop diuretics: may cause rapid electrolyte shifts.

Moderate Interactions (Monitor Closely): - ACE inhibitors: monitor blood pressure and electrolyte balance. - Beta‑agonists: may affect calcium homeostasis. - Alkalinising antibiotics: may alter bicarbonate effect.